Showing results (41-50 of 71) with videos related to
Sort By:
Pageof 8
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 26, 2019
A single-blind, randomised controlled trial of StrataXRT® - A silicone-based film-forming gel dressing for prophylaxis and management of radiation dermatitis in patients with head and neck cancerRaymond J Chan, Rae Blades, Lee Jones, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 22, 2017
Co-administration of RANKL and CTLA4 Antibodies Enhances Lymphocyte-Mediated Antitumor Immunity in MiceElizabeth Ahern, Heidi Harjunpää, Deborah Barkauskas, et al.Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|September 2, 2020
Determining the CA19-9 concentration that best predicts the presence of CT-occult unresectable features in patients with pancreatic cancer: A population-based analysisWilliam McGahan, Mary A Waterhouse, Dianne L O'Connell, et al.BMC Cancer|September 9, 2011
Safety, feasibility and effects of an individualised walking intervention for women undergoing chemotherapy for ovarian cancer: a pilot studyMelissa J Newton, Sandi C Hayes, Monika Janda, et al.HPB : the Official Journal of the International Hepato Pancreato Biliary Association|May 2, 2015
A prospective study of the impact of fluorodeoxyglucose positron emission tomography with concurrent non-contrast CT scanning on the management of operable pancreatic and peri-ampullary cancersMatthew E Burge, Nick O'Rourke, David Cavallucci, et al.Qualitative Health Research|June 23, 2020
The (Co)Production of Difference in the Care of Patients With Cancer From Migrant BackgroundsAlex Broom, Rhiannon Parker, Stephanie Raymond, et al.Asia-Pacific Journal of Clinical Oncology|January 23, 2016
Using a Delphi process to determine optimal care for patients with pancreatic cancerElizabeth A Burmeister, Susan J Jordan, Dianne L O'Connell, et al.Gynecologic Oncology|December 4, 2010
Prospective, non-randomized phase 2 clinical trial of carboplatin plus paclitaxel with sequential radical pelvic radiotherapy for uterine papillary serous carcinomaAndreas Obermair, Linda Mileshkin, Katharina Bolz, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 13, 2021
Dual PET Imaging in Bronchial Neuroendocrine Neoplasms: The NETPET Score as a Prognostic BiomarkerDavid L Chan, Gary A Ulaner, David Pattison, et al.Oncotarget|July 18, 2020
Australian experience of peptide receptor radionuclide therapy in lung neuroendocrine tumoursLisi Elizabeth Lim, David L Chan, David Thomas, et al.Pageof 8